Other

Pfizer in talks on $5 billion acquisition: media

American drugmaker Pfizer is close to a deal to purchase Global Blood Therapeutics, which manufactures a recently approved drug against sickle-cell anemia, for $5 billion, the Wall Street Journal has reported.

Diseases, Conditions, Syndromes

Pfizer says tweaked COVID-19 shots boost omicron protection

Pfizer announced Saturday that tweaking its COVID-19 vaccine to better target the omicron variant is safe and works—just days before regulators debate whether to offer Americans updated booster shots this fall.

Diseases, Conditions, Syndromes

COPD patients respond equally well to COVID-19 vaccine

A study that tested the immune response of COPD patients to COVID-19 vaccination has shown they respond in a similar way to healthy people. The findings by scientists from The University of Manchester and published as a research ...

Diseases, Conditions, Syndromes

FDA panel to decide on novavax COVID vaccine

A U.S. Food and Drug Administration vaccine advisory panel will weigh whether to recommend the emergency use of Novavax's COVID-19 vaccine on Tuesday.

page 7 from 40